Ritu Lal
Publications by Year
Research Areas
Gastroesophageal reflux and treatments, Pharmacological Effects and Toxicity Studies, Parkinson's Disease Mechanisms and Treatments, Epilepsy research and treatment, Helicobacter pylori-related gastroenterology studies
Most-Cited Works
- → ABT-378, a Highly Potent Inhibitor of the Human Immunodeficiency Virus Protease(1998)468 cited
- → Influence of Cardiac Output on Dexmedetomidine Pharmacokinetics(2000)120 cited
- → Arbaclofen Placarbil, a Novel R-Baclofen Prodrug: Improved Absorption, Distribution, Metabolism, and Elimination Properties Compared with R-Baclofen(2009)84 cited
- → Arbaclofen Placarbil Decreases Postprandial Reflux in Patients With Gastroesophageal Reflux Disease(2009)79 cited
- → Clinical pharmacokinetic drug interaction studies of gabapentin enacarbil, a novel transported prodrug of gabapentin, with naproxen and cimetidine(2010)55 cited
- → Pharmacokinetics and tolerability of single escalating doses of gabapentin enacarbil: A randomized-sequence, double-blind, placebo-controlled crossover study in healthy volunteers(2009)47 cited
- → A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study to Assess the Pharmacokinetics, Efficacy, and Safety of Gabapentin Enacarbil in Subjects With Restless Legs Syndrome(2012)43 cited
- → Actively Transported Levodopa Prodrug XP21279(2012)35 cited
- → Clinical Pharmacokinetics of Gabapentin After Administration of Gabapentin Enacarbil Extended-Release Tablets in Patients With Varying Degrees of Renal Function Using Data From an Open-Label, Single-Dose Pharmacokinetic Study(2011)29 cited
- → Population Pharmacokinetics and Pharmacodynamics of Gabapentin After Administration of Gabapentin Enacarbil(2012)27 cited